These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 20945415)

  • 1. Regulation of FGF-2 by an endogenous antisense RNA: effects on cell adhesion and cell-cycle progression.
    MacFarlane LA; Murphy PR
    Mol Carcinog; 2010 Dec; 49(12):1031-44. PubMed ID: 20945415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic fibroblast growth factor (FGF-2) overexpression is a risk factor for esophageal cancer recurrence and reduced survival, which is ameliorated by coexpression of the FGF-2 antisense gene.
    Barclay C; Li AW; Geldenhuys L; Baguma-Nibasheka M; Porter GA; Veugelers PJ; Murphy PR; Casson AG
    Clin Cancer Res; 2005 Nov; 11(21):7683-91. PubMed ID: 16278388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous fibroblast growth factors maintain viability, promote proliferation, and suppress GADD45alpha and GAS6 transcript content of prostate cancer cells genetically modified to lack endogenous FGF-2.
    Shain SA
    Mol Cancer Res; 2004 Nov; 2(11):653-61. PubMed ID: 15561781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fibroblast growth factor-2 antisense gene inhibits nuclear accumulation of FGF-2 and delays cell cycle progression in C6 glioma cells.
    Baguma-Nibasheka M; Li AW; Murphy PR
    Mol Cell Endocrinol; 2007 Mar; 267(1-2):127-36. PubMed ID: 17306451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective cyclooxygenase-2 inhibition suppresses basic fibroblast growth factor expression in human esophageal adenocarcinoma.
    Baguma-Nibasheka M; Barclay C; Li AW; Geldenhuys L; Porter GA; Blay J; Casson AG; Murphy PR
    Mol Carcinog; 2007 Dec; 46(12):971-80. PubMed ID: 17477358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.
    Zheng HQ; Zhou Z; Huang J; Chaudhury L; Dong JT; Chen C
    Oncogene; 2009 Oct; 28(42):3702-13. PubMed ID: 19668233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of small interfering RNA targeting basic fibroblast growth factor on proliferation and apoptosis of glioma cell line U251].
    Wang SJ; Wang JH; Zhang YW; Xu XN; Liu HS
    Ai Zheng; 2008 Sep; 27(9):905-9. PubMed ID: 18799025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of YB-1 gene knockdown on human leukemia cell line K562/A02].
    Xu WL; Zhou LL; Chen QY; Chen C; Fang LL; Fang XJ; Shen HL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Aug; 26(4):400-5. PubMed ID: 20017303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. siRNA-mediated knockdown against CDCA1 and KNTC2, both frequently overexpressed in colorectal and gastric cancers, suppresses cell proliferation and induces apoptosis.
    Kaneko N; Miura K; Gu Z; Karasawa H; Ohnuma S; Sasaki H; Tsukamoto N; Yokoyama S; Yamamura A; Nagase H; Shibata C; Sasaki I; Horii A
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1235-40. PubMed ID: 19878654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous fibroblast growth factor-1 or fibroblast growth factor-2 modulate prostate cancer cell proliferation.
    Shain SA; Sarić T; Ke LD; Nannen D; Yoas S
    Cell Growth Differ; 1996 May; 7(5):573-86. PubMed ID: 8732667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor 8 increases breast cancer cell growth by promoting cell cycle progression and by protecting against cell death.
    Nilsson EM; Brokken LJ; Härkönen PL
    Exp Cell Res; 2010 Mar; 316(5):800-12. PubMed ID: 19962979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
    Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
    Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor-2 modulates melanoma adhesion and migration through a syndecan-4-dependent mechanism.
    Chalkiadaki G; Nikitovic D; Berdiaki A; Sifaki M; Krasagakis K; Katonis P; Karamanos NK; Tzanakakis GN
    Int J Biochem Cell Biol; 2009 Jun; 41(6):1323-31. PubMed ID: 19110070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.
    Tsai MF; Wang CC; Chang GC; Chen CY; Chen HY; Cheng CL; Yang YP; Wu CY; Shih FY; Liu CC; Lin HP; Jou YS; Lin SC; Lin CW; Chen WJ; Chan WK; Chen JJ; Yang PC
    J Natl Cancer Inst; 2006 Jun; 98(12):825-38. PubMed ID: 16788156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
    Rahman KW; Li Y; Wang Z; Sarkar SH; Sarkar FH
    Cancer Res; 2006 May; 66(9):4952-60. PubMed ID: 16651453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The procyanidin-mediated induction of apoptosis and cell-cycle arrest in esophageal adenocarcinoma cells is not dependent on p21(Cip1/WAF1).
    Pierini R; Kroon PA; Guyot S; Johnson IT; Belshaw NJ
    Cancer Lett; 2008 Nov; 270(2):234-41. PubMed ID: 18562088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of fibroblast growth factor 2 expression by antisense RNA induced a loss of the transformed phenotype in a human hepatoma cell line.
    Maret A; Galy B; Arnaud E; Bayard F; Prats H
    Cancer Res; 1995 Nov; 55(21):5075-9. PubMed ID: 7585554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins.
    Chaturvedi P; Singh AP; Moniaux N; Senapati S; Chakraborty S; Meza JL; Batra SK
    Mol Cancer Res; 2007 Apr; 5(4):309-20. PubMed ID: 17406026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle.
    Yu YN; Yip GW; Tan PH; Thike AA; Matsumoto K; Tsujimoto M; Bay BH
    Int J Oncol; 2010 Aug; 37(2):483-92. PubMed ID: 20596676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of MIF leads to cell cycle arrest and apoptosis in pancreatic cancer cells.
    Denz A; Pilarsky C; Muth D; Rückert F; Saeger HD; Grützmann R
    J Surg Res; 2010 May; 160(1):29-34. PubMed ID: 19726058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.